Geode Capital Management, LLC Fennec Pharmaceuticals Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 299,298 shares of FENC stock, worth $1.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

299,298

Previous 301,578 0.76%

Holding current value

$1.39 Million

Previous $1.84 Million 18.78%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$4.85 - $6.73 $11,058 - $15,344	-2,280 Reduced 0.76%	299,298 $1.5 Million
Q2 2024 Aug 09, 2024	BUY	$6.02 - $10.99 $492,580 - $899,245	81,824 Added 37.23%	301,578 $1.84 Million
Q1 2024 May 13, 2024	BUY	$8.82 - $11.12 $10,266 - $12,943	1,164 Added 0.53%	219,754 $2.44 Million
Q4 2023 Feb 13, 2024	BUY	$6.48 - $11.61 $80,293 - $143,859	12,391 Added 6.01%	218,590 $2.45 Million
Q3 2023 Nov 13, 2023	BUY	$7.15 - $8.94 $66,652 - $83,338	9,322 Added 4.73%	206,199 $1.55 Million
Q2 2023 Aug 11, 2023	BUY	$7.27 - $9.82 $1.29 Million - $1.74 Million	177,370 Added 909.26%	196,877 $1.74 Million
Q1 2022 May 13, 2022	SELL	$4.29 - $6.08 $480 - $680	-112 Reduced 0.57%	19,507 $109,000
Q4 2021 Feb 11, 2022	SELL	$3.89 - $10.01 $1,128 - $2,902	-290 Reduced 1.46%	19,619 $86,000
Q3 2021 Nov 12, 2021	BUY	$6.51 - $9.62 $12,909 - $19,076	1,983 Added 11.06%	19,909 $187,000
Q2 2021 Aug 13, 2021	SELL	$5.96 - $7.85 $902,522 - $1.19 Million	-151,430 Reduced 89.42%	17,926 $130,000
Q1 2021 May 12, 2021	BUY	$6.21 - $8.68 $9,395 - $13,132	1,513 Added 0.9%	169,356 $1.05 Million
Q4 2020 Feb 12, 2021	BUY	$5.99 - $8.55 $72,215 - $103,078	12,056 Added 7.74%	167,843 $1.25 Million
Q3 2020 Nov 13, 2020	BUY	$5.19 - $10.17 $28,996 - $56,819	5,587 Added 3.72%	155,787 $944,000
Q2 2020 Aug 13, 2020	BUY	$5.43 - $9.39 $815,586 - $1.41 Million	150,200 New	150,200 $1.25 Million
Q2 2019 Aug 14, 2019	SELL	$3.3 - $5.09 $151,994 - $234,440	-46,059 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$4.64 - $7.58 $30,484 - $49,800	6,570 Added 16.64%	46,059 $223,000
Q4 2018 Feb 13, 2019	BUY	$5.37 - $8.39 $29,218 - $45,649	5,441 Added 15.98%	39,489 $251,000
Q3 2018 Nov 13, 2018	BUY	$7.84 - $10.83 $37,624 - $51,973	4,799 Added 16.41%	34,048 $279,000
Q2 2018 Aug 14, 2018	BUY	$10.05 - $14.33 $293,952 - $419,138	29,249 New	29,249 $305,000

Others Institutions Holding FENC

# of Institutions

Shares Held

14.9M

Call Options Held

10K

Put Options Held

83.8K

View Full List

About FENNEC PHARMACEUTICALS INC.

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $121M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

More about FENC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Fennec Pharmaceuticals Inc. Transaction History